ClinicalTrials.gov
public full text
Public Domain
CAR T Cells in Mesothelin-Expressing Breast Cancer
Phase 1 - Safety and Proof of Concept
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study#143674
- Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.#899482
- GPC3/Mesothelin-CAR-γδT Cells Against Cancers#879860
- The mechano-immunological landscape in the tumor microenvironment: From mechanical sensing to a new therapeutic paradigm#307852
- MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer#826793
Record · ID 850621
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive